Xianheng International Science&Technology Co., Ltd. (SHA:605056)
China
· Delayed Price · Currency is CNY 25.58
0.00 (0.00%)
Apr 29, 2026, 3:00 PM CST
SHA:605056 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 4,561 | 3,604 | 2,926 | 2,121 | 1,991 | Upgrade
|
| Other Revenue | - | 1.97 | 1.45 | 2.41 | 1.94 | Upgrade
|
| Revenue | 4,561 | 3,606 | 2,928 | 2,124 | 1,993 | Upgrade
|
| Revenue Growth (YoY) | 26.48% | 23.15% | 37.87% | 6.59% | 0.08% | Upgrade
|
| Cost of Revenue | 3,459 | 2,542 | 1,992 | 1,295 | 1,163 | Upgrade
|
| Gross Profit | 1,102 | 1,064 | 935.97 | 829.08 | 829.55 | Upgrade
|
| Selling, General & Admin | 631.91 | 637.28 | 613.98 | 487.75 | 519.92 | Upgrade
|
| Research & Development | 76.52 | 67.65 | 55.68 | 46.45 | 33.66 | Upgrade
|
| Other Operating Expenses | 13.47 | 17.95 | 15.69 | 12.27 | 10.1 | Upgrade
|
| Operating Expenses | 721.9 | 749.24 | 703.09 | 562 | 569.7 | Upgrade
|
| Operating Income | 380.05 | 314.26 | 232.88 | 267.08 | 259.85 | Upgrade
|
| Interest Expense | - | -1.34 | -2.1 | -1.54 | -0.69 | Upgrade
|
| Interest & Investment Income | 2.11 | 9.53 | 10.81 | 19.19 | 7.77 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.14 | 0.1 | -0.36 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.36 | -2.53 | -0.29 | -1.99 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | 375.8 | 319.79 | 241.4 | 282.38 | 266.28 | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.28 | -9 | -100.3 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.37 | 0.29 | 0.04 | -0.35 | -0.25 | Upgrade
|
| Asset Writedown | -5.24 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 3.46 | 5.05 | 5.45 | 7.32 | Upgrade
|
| Pretax Income | 363.9 | 314.54 | 146.19 | 287.47 | 273.35 | Upgrade
|
| Income Tax Expense | 83.76 | 74.85 | 37.9 | 69.19 | 66.6 | Upgrade
|
| Earnings From Continuing Operations | 280.15 | 239.69 | 108.29 | 218.29 | 206.76 | Upgrade
|
| Minority Interest in Earnings | -20.55 | -16.76 | -11.65 | -11.39 | -7.9 | Upgrade
|
| Net Income | 259.59 | 222.93 | 96.64 | 206.9 | 198.86 | Upgrade
|
| Net Income to Common | 259.59 | 222.93 | 96.64 | 206.9 | 198.86 | Upgrade
|
| Net Income Growth | 16.45% | 130.67% | -53.29% | 4.04% | -16.28% | Upgrade
|
| Shares Outstanding (Basic) | 399 | 405 | 403 | 398 | 375 | Upgrade
|
| Shares Outstanding (Diluted) | 399 | 405 | 403 | 398 | 375 | Upgrade
|
| Shares Change (YoY) | -1.47% | 0.66% | 1.21% | 6.04% | 4.26% | Upgrade
|
| EPS (Basic) | 0.65 | 0.55 | 0.24 | 0.52 | 0.53 | Upgrade
|
| EPS (Diluted) | 0.65 | 0.55 | 0.24 | 0.52 | 0.53 | Upgrade
|
| EPS Growth | 18.18% | 129.17% | -53.85% | -1.89% | -19.70% | Upgrade
|
| Free Cash Flow | 500.61 | 190.93 | 204.42 | 183.97 | 76.33 | Upgrade
|
| Free Cash Flow Per Share | 1.25 | 0.47 | 0.51 | 0.46 | 0.20 | Upgrade
|
| Dividend Per Share | - | 0.360 | 0.150 | 0.350 | 0.750 | Upgrade
|
| Dividend Growth | - | 140.00% | -57.14% | -53.33% | - | Upgrade
|
| Gross Margin | 24.16% | 29.50% | 31.97% | 39.04% | 41.63% | Upgrade
|
| Operating Margin | 8.33% | 8.72% | 7.95% | 12.58% | 13.04% | Upgrade
|
| Profit Margin | 5.69% | 6.18% | 3.30% | 9.74% | 9.98% | Upgrade
|
| Free Cash Flow Margin | 10.98% | 5.29% | 6.98% | 8.66% | 3.83% | Upgrade
|
| EBITDA | 407.76 | 340.79 | 255.84 | 283.62 | 281.3 | Upgrade
|
| EBITDA Margin | 8.94% | 9.45% | 8.74% | 13.36% | 14.12% | Upgrade
|
| D&A For EBITDA | 27.71 | 26.54 | 22.96 | 16.54 | 21.45 | Upgrade
|
| EBIT | 380.05 | 314.26 | 232.88 | 267.08 | 259.85 | Upgrade
|
| EBIT Margin | 8.33% | 8.72% | 7.95% | 12.58% | 13.04% | Upgrade
|
| Effective Tax Rate | 23.02% | 23.80% | 25.92% | 24.07% | 24.36% | Upgrade
|
| Revenue as Reported | - | 3,606 | 2,928 | 2,124 | 1,993 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.